Introduction
In analogy to their replication-competent ancestors 1, 2 , the semi-random insertion of replicationdeficient retrovirus-based vectors may alter cell fate by up-regulating cellular proto-oncogenes or disrupting tumor suppressor genes [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Such forms of insertional mutagenesis have always represented a safety concern in the development of human gene therapy, although initial studies did not reveal major consequences of random vector insertions 13 . The advent of sensitive technologies to detect vector insertion sites in mixed samples [14] [15] [16] , the completion of the murine and human genome projects 17 , the design of improved animal models with long-term follow-up 3, 18 , and the increasing efficiency of retrovirus-mediated gene delivery in clinical trials 9, [19] [20] [21] [22] have all contributed to a revised interpretation of vector-mediated insertional mutagenesis. Clonal imbalance triggered by vector insertion is thus expected to represent the rule rather than the exception [23] [24] [25] .
Preclinical models and clinical trials revealed that the semi-random insertion of retrovirus-based vectors in the genome of long-term repopulating hematopoietic cells may increase self-renewal and/or initiate malignant transformation [3] [4] [5] [6] [7] [8] [9] [10] [11] . Increased self-renewal can be transitory, resulting in clonal succession such that a given dominant clone is replaced by others over time 4, 9, 11 . It is likely, although not always formally shown, that replication stress as caused by extended culture of cells prior to transplantation 5 , serial bone marrow transplantation (BMT) in myeloablated recipients 3 , cytotoxic chemotherapy 10 , or chronic infection 9 may trigger the clonal dominance. Long-term observation is required to detect such clones, as the growth kinetics of insertional mutants may be relatively slow and multiple competitor cells are often co-transplanted or present in the host 3, 4, 10 .
If more than one proto-oncogene is up-regulated by random vector insertion 5 , tumor-promoting sequences are encoded by the vector 7 , or cells with pre-existing tumor-promoting lesions are transduced 26 , clonal leukemias, lymphomas or sarcomas may result in consequence of random vector insertion, as previously observed in studies with replication-competent retroviruses (RCRs) such as murine leukemia virus (MLV) 1, 2, 12 . In contrast, clonal dominance was not detected following retroviral vector-mediated gene transfer in transplanted T cells, although a fifth of the RVIS affected the expression of neighboring genes 27 . This supports the conclusion that clonal selection requires a trias consisting of dysregulated expression of genes that regulate cell fitness, a cell type with extensive selfrenewal potential, and a milieu with a selection pressure for the fittest mutants.
Our work has focused on a relatively simple serial BMT model in C57Bl6 mice. The "normal" genetic background of this strain, the relatively low incidence of host-derived tumors (<3% under our 4 experimental conditions), and the availability of an allelic variant in the CD45 panleukocyte antigen in a congenic strain (B6 CD45.1) to distinguish donor and host cells render this model particularly attractive for gene discovery by and preclinical safety studies of retroviral gene transfer into hematopoietic cells.
In the present report, we summarize data from several laboratories that used this model to develop a database of retroviral vector insertion sites (RVIS) detected in dominant clones contributing to phenotypically intact, mildly dysplastic and overtly malignant hematopoiesis. We describe the validation of our experimental conditions to detect genetic lesions underlying clonal dominance, and several important genetic and biological insights obtained from the newly established "insertional dominance database" (IDDb). These analyses underline the validity of our approach to discover genes that regulate fitness and potentially transform self-renewing cells in vivo, promoting a systematic extension for both gene discovery and vector biosafety studies in the context of different cell types and selection conditions.
Materials and methods

Transplant conditions and analysis of healthy and leukemic hematopoiesis in mice
All BMT studies were performed in C57Bl6 mice. In brief, donor bone marrow cells were cultured ex vivo to stimulate gene transfer using vectors based on MLV, and cells were transplanted into lethally irradiated recipients aged 12-16 weeks. Mice were kept in the animal facilities of the participating institutions, according to local animal experimentation guidelines. Food and water were supplied ad libitum. Table 1 summarizes the transplant conditions and vectors used (see Supplemental data for further details). Mice were euthanized when symptomatic (leukemic) or after 2.5-7 months in the healthy cases and examined for pathological abnormalities including histological, morphological (blood smears and cytospins of bone marrow and spleen) and flow cytometry analyses 5 .
Cell culture
K562 cells were cultivated and transduced as described 28 .
Ligation-mediated (LM) PCR
LMPCR was performed as described 4, 5, 15 .
Insertion site analysis
Fragments containing retroviral genomic junctions were submitted to further analysis using the following websites: BLAST searches were performed at http://www.ncbi.nlm.nih.gov/BLAST or in some cases at Ensemble Web site http://www.ensembl.org; the mouse retrovirus tagged cancer gene databases (RTCGD) at http://rtcgd.ncifcrf.gov; the stem cell database (SCDb) at http://stemcell.princeton.edu. Gene Ontology (GO) describes gene biological roles and is arranged in a quasi-hierarchical structure from more general terms to more specific. To determine abundance for each GO category, the frequency of retroviral inserts was calculated and compared to the expected frequency observed by chance, as described 29 . GO analysis was confirmed by the Expression Analysis Systematic Explorer (EASE) http://david.niaid.nih.gov/david/ease.htm .
Expression arrays
C57Bl6 bone marrow cells were depleted for lineage-committed cells (CD5, CD45R (B220), CD11b, . The expression data were normalised as described 31, 32 . For each gene, the highest expression was determined. For some, only the most highly expressed probe set was used. To determine the association of vector insertion with gene expression, a Cochran-Armitage test for trend was performed 33 .
Pathway Analysis
Gene symbols were entered into Netaffx (http://www.Affymetrix.com) and the corresponding Affymetrix
IDs for the mouse 430 2.0 arrays were retrieved. The resulting Affymetrix IDs were entered in the Ingenuity Pathway Analysis tool (http://www.ingenuity.com) to generate direct and indirect pathways.
For each dataset, the 10 functions and diseases with the most genes assigned to it are displayed. 
Results
Experimental Setup
The RVIS described in this study are derived from murine experiments (mostly C57Bl6), using several replication-deficient MLV-based vectors for gene transfer into ex vivo cultured hematopoietic cells. The vectors used include a group encoding fluorescent proteins (EGFP, DsRed), a group encoding transmembrane proteins that serve as selection markers (dLNGFR, human tCD34 and flCD34, murine tCD34 and flCD34, MDR1) and a vector expressing a gene associated with DNA repair (XRCC4). As a positive control for a transforming vector expressing a strong oncogene, the largeT antigen (TAg) from simian virus 40 (SV40) was used ( Figure 1 ). TAg transforms cells by sequestering two tumor suppressor genes, Rb and p53 34 . The transforming potential of the TAg vector was initially evaluated in 32D cells, revealing insertion sites with potential contribution to transformation (Z. L. unpublished data). Four RVIS from these studies were also included in the IDDb (1.4% of the database).
If the vectors do not encode oncogenic sequences, RVIS present in dominant clones may mark events that initiate increased self-renewal 4 . Importantly, we noted transcriptional dysregulation of the mutated alleles in all cases tested so far 4 . If the vectors encode oncogenic sequences such as TAg, the insertional events may either collaborate with the encoded oncogene to initiate tumor formation, or promote the expansion of dominant malignant clones whose initial transformation is primarily dependent on the vector-encoded oncogene 7 . Mice were prospectively examined for several months; in a subset of the studies, serial BMT was performed to increase replicative stress and observation time ( Figure 1 and Table 1 ). 
Validation of LMPCR
Different methods have been described to recover insertion sites from retrovirally transduced cells [14] [15] [16] 27, 35, 36 . To identify insertion sites of dominant clones, it was crucial to neglect insertion sites present in minor clones. Ligation-mediated PCR (LMPCR) as opposed to the much more sensitive "linear amplification mediated PCR" (LAMPCR) has previously been shown to lack the sensitivity to detect all insertion sites present in highly polyclonal samples 16 . However, we noted that the bands obtained by LMPCR correlated well with Southern blot results obtained in clonal samples, and recovery of RVIS was in the range of 80% when using a single restriction enzyme 4, 5, 37 . We thus decided to select dominant bands that are isolated from analytical gels for direct sequencing, ignoring weak bands that might reflect insertion sites present in minor clones. Direct sequencing of the PCR product confirmed the presence of RVIS (data not shown). We typically perform two LMPCRs to confirm reproducibility.
Composition and content of the IDDb
The sequence data obtained by LMPCR were blasted against the mouse genome to identify genes potentially affected by the insertion site. We also examined whether the hit loci were contained in the RTCGD 2 , and listed the experimental conditions as these may impact on selection (vector, transplant conditions and potential development of malignancy, supplementary Table 1 ). In total, we identified in mice with normal hematopoiesis ( Figure 3A) . Thus, the IDDb perfectly reproduced the findings of our previous study performed in mice that showed no signs of hematopoietic malignancies 4 .
Considering that proto-oncogenes represent 1.06% (n=231) of the murine genome (Entrez Gene 11
May 2006), this is a gross over-representation. For comparison, 37% of the RVIS recovered from leukemias were in or close to proto-oncogenes ( Figure 3A) , strongly suggesting that the RVIS were causally involved in promoting a competitive advantage and inducing transformation 5 .
We next asked whether the different transgenes encoded by the vectors affected clonal selection. We subdivided the hit genes into four groups: proto-oncogenes as defined by the RTCGD 2 and additional literature, signaling genes, other genes and unknown genes. EGFP and DsRed encode fluorescent proteins which are not known to cause significant changes of signaling networks. 25% (n=70) of the hits were recovered using these vectors. In this subgroup, the distribution of hits in the four gene groups was almost identical to that obtained within the set of transgenes that encode marker proteins for which an impact on cellular signaling cannot be ruled out (MDR1, dLNGFR, human tCD34, human , it is interesting that only 52% of the IDDb-CRVIS represent known proto-oncogenes (Table 2 ). Summarizing all RVIS in known proto-oncogenes, those forming novel CRVIS in our database and those occurring in genes with an established role in stem cell self-renewal and hematopoiesis, a group of at least 48 genes encoding growth factors, signal transducers and transcription factors can be extracted which represent interesting candidates for future functional studies (Table 2) . Interestingly, 81% of these RVIS were found in secondary and/or leukemic transplant recipients.
Insertion site distribution in relation to the transcription start site
To further address the potential selective pressure present on the mutated alleles, we analyzed the distribution of the RVIS with respect to the transcriptional start site (TSS) of the next neighboring gene.
In unselected freshly transduced cells, MLV vectors have a preference for insertions in the 10 kb window around the TSS 35 , with a peak in the +/-1kb window 36 , whereas HIV and derived vectors tend to prefer actively transcribed sequences, in particular beyond +2 kb downstream of the TSS 35, 36, 39 . The reference data obtained in previous studies (kindly provided by D. Russell and G.
Trobridge, Ref. 36 ) are shown in Figure 4A (lines), in comparison with our database (columns). For this comparison, we divided the IDDb hits into four classes: class 1 consists of known self-renewal genes, proto-oncogenes, and CRVIS present in the IDDb (see Table 2 Verstegen, G.W., manuscript in preparation), and the third database was generated using the same array and RNA extracted from highly purified hematopoietic stem cells (side population (SP) combined with LSK) 42 (S.M.C. and M.A.G., unpublished data).
We found 57% of the class 1 genes to be listed in the SCDb, as opposed to 32% for class 2 and 11 % for class 3. With reference to the GO classification used in the SCDb, the IDDb shows an overrepresentation of genes encoding proteins involved in apoptosis, intracellular signaling, or transcriptional control, whereas the following gene classes are strongly under-represented: cell adhesion, transport, chromatin regulators, protein processing, and protein synthesis (Table 3) .
We further studied GO in its branching into a semi-hierarchical tree, describing genes in categories (Table 4) . Strikingly, most of the genes extracted in Table 2 are connected in two major networks ( Figure 5 ). Table 2 reveal two major pathways (A,B). Note that further members of these pathways may be highlighted when extending the analysis to the full IDDb. E.g., Siva shown on the bottom of Figure 5A is a chromosomal neighbor of Akt1; this locus represents a CRVIS in the IDDb (Table 2  and supplementary Table 1 ).
This suggested that the RVIS selected in the IDDb occurred preferentially in a subset of genes ex- Interestingly, the level of significance increased depending on serial transplantation and the degree of transformation: primary recipients (p=0.0027), secondary recipients (p=0.000017) and leukemias (p=0.0000013). This reveals that the vast majority of genes whose de-regulation causes clonal dominance is already expressed in primitive hematopoietic cells, rather than being activated from a silent state upon insertional mutagenesis.
As the initial target population of retroviral gene transfer was not such a highly purified fraction, we also used gene expression array data from LSK cells to check whether the level of transcription correlates with RVIS. LSK cells contain both short-term and long-term repopulating cells 43 , and it is possible that some RVIS converted short-term to long-term clones, as can be observed in consequence of certain oncogenic translocations 44 Figure 6A,B) . Comparing freshly isolated and cultured LSK cells, no major impact of culture conditions on the insertion profile was noted ( Figure 6A,B) . Interestingly, the association of RVIS with highly expressed genes was more pronounced in class 1 than in classes 2 and 3 ( Figure 6C ).
Remarkably, the probability of forming a CRVIS does not seem to depend on the expression level.
CRVIS are evenly distributed over all expression levels ( Figure 6D ) and even found in regions without transcriptional activity. A similar trend was observed for CRVIS that were hit three or more times; Evi1, the most frequent CRVIS in our dataset, does not show the highest expression level in the array ( Figure 6D ). Together, these data confirm the hypothesis that the risk of retroviral vector insertion in a given locus depends upon its expression level in the target cell. However, the selection for CRVIS is not a sole function of the initial expression level. We conclude that CRVIS are selected based on the biological consequences of target gene dysregulation and do not necessarily reflect a higher probability of retroviral integration. .
Discussion
The present study introduces a novel database (IDDb) listing RVIS associated with clonal dominance in cases of normal, potentially preleukemic hematopoiesis or malignant transformation of hematopoietic cells. We showed that our experimental conditions select RVIS of dominant clones that contribute the majority (>>50%) of a polyclonal population. Under our experimental conditions that involve a rather profound replication stress, the dysregulated cellular genes most likely have the potential to promote proliferation and/or survival of long-term repopulating hematopoietic cells.
Consistent with present concepts of oncogenesis and leukemogenesis 45, 46 , GO analysis revealed that three major gene functions contribute to clonal dominance: regulation of proliferation, apoptosis and transcription. More importantly, pathway studies revealed that these genes are functionally connected in two major signalling networks ( Figure 5 ). Of note, many of the genes listed in these classes have previously not been implicated in HSC biology.
Another important conclusion was that those genes which contribute to clonal dominance following The leukemias occurring in our model typically require combinatorial genetic lesions, either by the presence of RVIS in more than one leukemia-promoting gene 5 , or by a single proto-oncogenic RVIS in combination with signal alterations evoked by the vector-encoded transgene 3 . Although animals were examined for hematopoietic abnormalities in compliance with recent recommendations 48, 49 , preleukemic clonal expansion might have been overlooked. Leukemogenic signal alterations are expected to be dose-related, as previously observed for Evi1 and Hoxb4 [50] [51] [52] . The potential utility of these genes for stem cell expansion will thus depend upon the ability to identify the required level of transcriptional dysregulation. Accordingly, we would assume that RVIS in such genes are only selected in vivo if the resulting extent of transcriptional dysregulation fits the selective pressure encountered in the given conditions. Insertional mutagenesis by RVIS may thus represent a powerful approach to identify genes that promote clonal survival under different selection conditions, such as exposure to cytotoxic drugs, inhibitory cytokines, irradiation, or disease-specific conditions.
Notably, not all IDDb entries can be considered as potential inducers of clonal dominance. Some genes may be accidentally marked in clones that contain more than one insertion, and intrinsic, potentially stochastic differences in cell fitness may also contribute to clonal dominance (reviewed in Ref. Table 2 and the genes involved in the networks presented in Figure 5 . However, only a smaller subset of these genes has previously been implicated to regulate "stemness". Examples are Akt1 which is known to be essential for self-renewal of murine embryonic stem cells 54 , Hoxb4 which stimulates HSC self-renewal without necessarily inducing leukemia 55 and Evi1 which triggers selfrenewal of myeloid progenitor cells in vitro and might give rise to a myelodysplastic syndrome and myeloid leukemia 6, 38 . Interestingly, Akt1 together with Foxo3a and Cyclin D regulates the hibernation of HSC 56 , and all three genes are found in the center of the network shown in Figure 5A . Other genes that are functionally related to the last two examples are also found: The IDDb (supplementary Table   1 Figure 1 for abbreviations of cDNAs. Table 2 . Insertions in known proto-oncogenes, genes with an established role in hematopoiesis, and common insertion sites in the insertional dominance 
